TY - JOUR
T1 - Ostreolysin A and anthrolysin O use different mechanisms to control movement of cholesterol from the plasma membrane to the endoplasmic reticulum
AU - Johnson, Kristen A.
AU - Endapally, Shreya
AU - Vazquez, Danya C.
AU - Infante, Rodney E.
AU - Radhakrishnan, Arun
N1 - Funding Information:
Acknowledgments—We thank Daphne Rye and Bilkish Bajaj for excellent technical assistance; Lisa Beatty, Briana Carter, Leticia Esparza, Shomanike Head, and Camille Harry for cell culture assistance; Feiran Lu and Dorothy Williams for assistance with ACAT assays; Linda Donnelly for assistance with 125I-LDL uptake and degradation assays; Ruth Gordillo (Touchstone Diabetes Center, University of Texas Southwestern) for MS analysis of cellular sphingomyelin; Jeff McDonald and Kaitlyn Eckert (Center for Human Nutrition, University of Texas Southwestern) for MS analysis of cellular cholesterol; and Kate Luby-Phelps, Marcel Mettlen, Sandra Schmid, Daniel Kober, and Shimeng Xu for helpful discussions. Confocal imaging was carried out at University of Texas Southwestern Medical Center Live Cell Imaging Facility using an instrument funded by National Institutes of Health 1S10OD021684-01 to Kate Luby-Phelps.
Funding Information:
This work was supported by National Institutes of Health Grant HL20948 (to A. R. and R. E. I.), Burroughs Wellcome Fund Grant 1019692 (to R. E. I.), American Gastroenterological Association Grant 2019AGARSA3 (to R. E. I.), and Robert A. Welch Foundation Grant I-1793 (to A. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding Information:
1 Recipient of a postdoctoral fellowship from the Hartwell Foundation.
Publisher Copyright:
© 2019 Johnson et al.
PY - 2019/11/15
Y1 - 2019/11/15
N2 - Recent studies using two cholesterol-binding bacterial toxin proteins, perfringolysin O(PFO) and domain 4 of anthrolysin O (ALOD4), have shown that cholesterol in the plasma membranes (PMs) of animal cells resides in three distinct pools. The first pool comprises mobile cholesterol, accessible to both PFO and ALOD4, that is rapidly transported to the endoplasmic reticulum (ER) to signal cholesterol excess and maintain cholesterol homeostasis. The second is a sphingomyelin (SM)-sequestered pool inaccessible to PFO and ALOD4 but that becomes accessible by treatment with SM-degrading sphingomyelinase (SMase). The third is an essential pool also inaccessible to PFO and ALOD4 that cannot be liberated by SMase treatment. The accessible cholesterol pool can be trapped on PMs of live cells by nonlytic ALOD4, blocking its transport to the ER. However, studies of the two other pools have been hampered by a lack of available tools. Here, we used ostreolysin A (OlyA), which specifically binds SM/cholesterol complexes in membranes, to study the SM-sequestered cholesterol pool. Binding of nonlytic OlyA to SM/cholesterol complexes in PMs of live cells depleted the accessible PM cholesterol pool detectable by ALOD4. Consequently, transport of accessible cholesterol from PM to ER ceased, thereby activating SREBP transcription factors and increasing cholesterol synthesis. Thus, OlyA and ALOD4 both control movement of PM cholesterol, but through different lipid-binding mechanisms. We also found that PM-bound OlyA was rapidly internalized into cells, whereas PM-bound ALOD4 remained on the cell surface. Our findings establish OlyA and ALOD4 as complementary tools to investigate cellular cholesterol transport.
AB - Recent studies using two cholesterol-binding bacterial toxin proteins, perfringolysin O(PFO) and domain 4 of anthrolysin O (ALOD4), have shown that cholesterol in the plasma membranes (PMs) of animal cells resides in three distinct pools. The first pool comprises mobile cholesterol, accessible to both PFO and ALOD4, that is rapidly transported to the endoplasmic reticulum (ER) to signal cholesterol excess and maintain cholesterol homeostasis. The second is a sphingomyelin (SM)-sequestered pool inaccessible to PFO and ALOD4 but that becomes accessible by treatment with SM-degrading sphingomyelinase (SMase). The third is an essential pool also inaccessible to PFO and ALOD4 that cannot be liberated by SMase treatment. The accessible cholesterol pool can be trapped on PMs of live cells by nonlytic ALOD4, blocking its transport to the ER. However, studies of the two other pools have been hampered by a lack of available tools. Here, we used ostreolysin A (OlyA), which specifically binds SM/cholesterol complexes in membranes, to study the SM-sequestered cholesterol pool. Binding of nonlytic OlyA to SM/cholesterol complexes in PMs of live cells depleted the accessible PM cholesterol pool detectable by ALOD4. Consequently, transport of accessible cholesterol from PM to ER ceased, thereby activating SREBP transcription factors and increasing cholesterol synthesis. Thus, OlyA and ALOD4 both control movement of PM cholesterol, but through different lipid-binding mechanisms. We also found that PM-bound OlyA was rapidly internalized into cells, whereas PM-bound ALOD4 remained on the cell surface. Our findings establish OlyA and ALOD4 as complementary tools to investigate cellular cholesterol transport.
UR - http://www.scopus.com/inward/record.url?scp=85074510385&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85074510385&partnerID=8YFLogxK
U2 - 10.1074/jbc.RA119.010393
DO - 10.1074/jbc.RA119.010393
M3 - Article
C2 - 31597703
AN - SCOPUS:85074510385
SN - 0021-9258
VL - 294
SP - 17289
EP - 17300
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 46
ER -